[Federal Register Volume 74, Number 107 (Friday, June 5, 2009)]
[Notices]
[Page 27040]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10050 and CMS-10174]


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services, HHS.

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid 
Services (CMS) is publishing the following summary of proposed 
collections for public comment. Interested persons are invited to send 
comments regarding this burden estimate or any other aspect of this 
collection of information, including any of the following subjects: (1) 
The necessity and utility of the proposed information collection for 
the proper performance of the agency's functions; (2) the accuracy of 
the estimated burden; (3) ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) the use of 
automated collection techniques or other forms of information 
technology to minimize the information collection burden.
    1. Type of Information Collection Request: Revision of the 
currently approved collection; Title of Information Collection: New 
Enrollee Survey; Use: The New Enrollee survey was developed to gather 
information from newly enrolled Medicare beneficiaries about their 
Medicare knowledge and needs. CMS is seeking understanding about what 
types of information new enrollees need and what they know about 
Medicare. Included in the survey are questions regarding how well 
informed new enrollees are about Medicare and what information they 
have received about the Medicare program. Information gathered in this 
survey will be used only for purposes of targeting and improving 
communications with newly eligible Medicare beneficiaries. Form Number: 
CMS-10050 (OMB<greek-i>: 0938-0869); Frequency: Reporting--Quarterly; 
Affected Public: Individuals or Households; Number of Respondents: 
1200; Total Annual Responses: 1200; Total Annual Hours: 300. (For 
policy questions regarding this collection contact Renee Clark at 410-
786-0006. For all other issues call 410-786-1326.)
    2. Type of Information Collection Request: Revision of the 
currently approved collection; Title of Information Collection: 
Collection of Drug Event Data From Contracted Part D Providers For 
Payment; Use: In December 2003, Congress enacted the Medicare 
Prescription Drug, Improvement, and Modernization Act of 2003 referred 
to as the Medicare Modernization Act (MMA). The Medicare Prescription 
Drug Benefit program (Part D) was established by section 101 of the MMA 
and is codified in section 1860D-1 through 1860 D-41 of the Social 
Security Act. Effective January 1, 2006, the Part D program establishes 
an optional prescription drug benefit for individuals who are entitled 
to Medicare Part A and/or enrolled in Part B. Part D plans have 
flexibility in terms of benefit design. This flexibility includes, but 
is not limited to, authority to establish a formulary that limits 
coverage to specific drugs within each therapeutic class of drugs, and 
the ability to have a cost-sharing structure other than the statutorily 
defined structure (subject to certain actuarial tests). Coverage under 
the new prescription drug benefit is provided predominately through 
private at-risk prescription drug plans that offer drug-only coverage 
(PDPs), Medicare Advantage (MA) plans that offer integrated 
prescription drug and health care coverage (MA-PD plans) or Cost Plans 
that offer prescription drug benefits.
    The transmission of the data will be in an electronic format. The 
information users will be Pharmacy Benefit Managers (PBM), third party 
administrators and pharmacies and the PDPs, MA-PDs, Fallbacks and other 
plans that offer coverage of outpatient prescription drugs under the 
Medicare Part D benefit to Medicare beneficiaries. The data is used 
primarily for payment, and is used for claim validation as well as for 
other legislated functions such as quality monitoring, program 
integrity and oversight. Form Number: CMS-10174 (OMB<greek-i>: 0938-
0982); Frequency: Reporting--Monthly; Affected Public: Business or 
other for-profits and Not-for-profit institutions; Number of 
Respondents: 747; Total Annual Responses: 947,881,770; Total Annual 
Hours: 1896. (For policy questions regarding this collection contact 
Bobbie Knickman at 410-786-4161. For all other issues call 410-786-
1326.)
    To obtain copies of the supporting statement and any related forms 
for the proposed paperwork collections referenced above, access CMS' 
Web site at http://www.cms.hhs.gov/PaperworkReductionActof1995, or e-
mail your request, including your address, phone number, OMB number, 
and CMS document identifier, to <a href="/cdn-cgi/l/email-protection#3b6b5a4b5e494c5449507b58564815535348155c544d"><span class="__cf_email__" data-cfemail="4d1d2c3d283f3a223f260d2e203e6325253e632a223b">[email protected]</span></a>, or call the 
Reports Clearance Office on (410) 786-1326.
    In commenting on the proposed information collections please 
reference the document identifier or OMB control number. To be assured 
consideration, comments and recommendations must be submitted in one of 
the following ways by August 4, 2009:
    1. Electronically. You may submit your comments electronically to 
http://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: Document Identifier/OMB 
Control Number (CMS-10078), Room C4-26-05, 7500 Security Boulevard, 
Baltimore, Maryland 21244-1850.

    Dated: May 28, 2009.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations 
and Regulatory Affairs.
[FR Doc. E9-13150 Filed 6-4-09; 8:45 am]
BILLING CODE 4120-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>